These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 22587342

  • 1. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.
    Cardin R, Piciocchi M, Sinigaglia A, Lavezzo E, Bortolami M, Kotsafti A, Cillo U, Zanus G, Mescoli C, Rugge M, Farinati F.
    BMC Cancer; 2012 May 15; 12():177. PubMed ID: 22587342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic impact of 8-hydroxy-deoxyguanosine and its repair enzyme 8-hydroxy-deoxyguanosine DNA glycosylase in hepatocellular carcinoma.
    Yugawa K, Itoh S, Yoshizumi T, Yoshiya S, Takeishi K, Toshima T, Harada N, Ikegami T, Kohashi K, Oda Y, Mori M.
    Pathol Int; 2020 Aug 15; 70(8):533-541. PubMed ID: 32419286
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, Yoneyama H, Kobayashi K, Kamada H, Guan Y, Nishiyama A, Okano K, Suzuki Y, Himoto T, Shimotohno K, Masaki T.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G401-G409. PubMed ID: 31905024
    [Abstract] [Full Text] [Related]

  • 10. The Relationship Between Single-Nucleotide Polymorphisms, the Expression of DNA Damage Response Genes, and Hepatocellular Carcinoma in a Polish Population.
    Krupa R, Czarny P, Wigner P, Wozny J, Jablkowski M, Kordek R, Szemraj J, Sliwinski T.
    DNA Cell Biol; 2017 Aug 01; 36(8):693-708. PubMed ID: 28598207
    [Abstract] [Full Text] [Related]

  • 11. Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma.
    Ichiba M, Maeta Y, Mukoyama T, Saeki T, Yasui S, Kanbe T, Okano J, Tanabe Y, Hirooka Y, Yamada S, Kurimasa A, Murawaki Y, Shiota G.
    Liver Int; 2003 Oct 01; 23(5):338-45. PubMed ID: 14708894
    [Abstract] [Full Text] [Related]

  • 12. HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.
    Shiu TY, Shih YL, Feng AC, Lin HH, Huang SM, Huang TY, Hsieh CB, Chang WK, Hsieh TY.
    J Mol Med (Berl); 2017 Jun 01; 95(6):629-639. PubMed ID: 28258280
    [Abstract] [Full Text] [Related]

  • 13. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.
    J Gastroenterol Hepatol; 2008 Sep 01; 23(9):1431-6. PubMed ID: 18854000
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.